← Back to Screener
OKYO Pharma Limited Ordinary Shares (OKYO)
Price$1.66
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-31.85%
Price vs S&P 500 (4W)1.30%
VGM Score50.26
Market Capitalization$117.57M
All Metrics
Book Value / Share (Quarterly)$9.14
P/TBV (Annual)19.88x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.11
Price vs S&P 500 (YTD)-29.26%
EPS (TTM)$-0.15
10-Day Avg Trading Volume0.05M
EPS Excl Extra (TTM)$-0.15
EPS (Annual)$-0.16
ROI (Annual)-177.68%
Cash / Share (Quarterly)$0.15
ROA (Last FY)-127.98%
EBITD / Share (TTM)$-0.20
Cash Flow / Share (Annual)$-0.07
P/B Ratio28.95x
P/B Ratio (Quarterly)38.89x
Net Income / Employee (Annual)$-1,584,047
Net Interest Coverage (TTM)-8.22x
ROA (TTM)-110.88%
EPS Incl Extra (Annual)$-0.16
Current Ratio (Annual)0.40x
Quick Ratio (Quarterly)0.53x
3-Month Avg Trading Volume0.17M
52-Week Price Return-2.86%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$-1.55
52-Week High$3.35
EPS Excl Extra (Annual)$-0.16
26-Week Price Return-18.27%
Quick Ratio (Annual)0.37x
13-Week Price Return-3.95%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.58x
Enterprise Value$81.86M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.06
3-Month Return Std Dev47.70%
Net Income / Employee (TTM)$-1,552,678
ROE (Last FY)-177.68%
Net Interest Coverage (Annual)-30.61x
EPS Basic Excl Extra (Annual)$-0.16
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.15
Receivables Turnover (Annual)0.00x
ROI (TTM)-133.11%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$11.58
Price vs S&P 500 (52W)-31.01%
Year-to-Date Return-17.87%
5-Day Price Return0.59%
EPS Normalized (Annual)$-0.16
ROA (5Y Avg)-329.24%
Month-to-Date Return-0.87%
Cash Flow / Share (TTM)$-38.68
EBITD / Share (Annual)$-0.24
EPS Basic Excl Extra (TTM)$-0.15
P/B Ratio (Annual)38.89x
Book Value / Share (Annual)$9.14
Price vs S&P 500 (13W)-14.62%
Beta0.06x
Revenue / Share (TTM)$0.00
ROE (TTM)-134.46%
52-Week Low$1.44
mGradeC
vgmGradeC
Show chart for
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.11
4.10
4.10
4.10
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OKYOOKYO Pharma Limited Ordinary Shares | — | — | C | $1.66 |
| AMGNAmgen Inc | C | C | C | $338.22 |
| GILDGilead Sciences Inc | C | B | C | $128.99 |
| ARGXargenx SE American Depositary Shares | D | A | B | $813.14 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $155.99 |
| BIIBBiogen Inc. Common Stock | B | D | C | $195.96 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.45 |
| MRNAModerna, Inc. Common Stock | C | B | C | $49.06 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $165.11 |
| EXELExelixis Inc | C | B | B | $51.60 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | B | $301.82 |
About
OKYO Pharma is a biopharmaceutical company developing innovative therapies for inflammatory eye diseases and chronic pain conditions. The company's pipeline targets key indications including Dry Eye Disease, Non-infectious Anterior Uveitis, Allergic Conjunctivitis, and chronic/ocular pain. It addresses underserved patient populations with significant unmet medical needs in ophthalmology and pain management.